The Ebola Endgame with Alana

Amidst reports that Ebola patients are being “disappeared” from hospitals and that the current strain of Ebola is weaponized, many people are wondering why the U.S. government seems to be acting negligent in responding to the outbreak.

The answer could lie in Obama’s 2014 State of the Union address and his recent choice of Ron Klain as Ebola czar. Klain, was a Partner and National Practice Group Chair of O’Melveny & Myers, LLP, a lobbying firm that represents the Chinese biotechnology firm WuXi PharmaTech. Last April, WuXi created a corporate venture fund to invest in TruTag, the makers of breakthrough edible microtags for pharmaceuticals that are “biologically inert, edible, and virtually invisible,” according to TruTag’s Website.

The site http://www.trutags.com/1961/wuxi-pharmatech-corporate-venture-fund-invest-trutag-security-platform-drug-safety/ says the dust-sized particles are “smaller than the width of a human hair,” that will allow “brand owners, including pharmaceutical companies” to “field-read finished tablets circulating in the wholesale and retail market to determine the authenticity of provenance of medicines, including detailed information such as site and date of manufacture, lots, and other critical data.” The site goes on to say that “WuXi and TruTag will explore collaborations to offer WuXi’s global customers the TruTag on-dose authentication solution to help prevent counterfeiting and to enhance drug safety.”

Last January, Obama touted his plans for a new industrial revolution and new trade partnerships with the Asia-Pacific during his State of the Union address that urged Congress to support research that will “unleash the next great American discovery – whether it’s vaccines that stay ahead of drug-resistant bacteria, or paper-thin material that’s stronger than steel.”